Quick Take

The FDA has issued a formal warning advising consumers to immediately stop using and avoid purchasing South Moon, Rebright, and FivFivGo eye drops. These "copycat" products pose a significant risk of bacterial contamination, which can lead to serious eye infections and potential vision loss.

Why It Matters

This alert follows a troubling trend of contaminated over-the-counter ophthalmic products entering the U.S. market through third-party online retailers. Unlike regulated pharmaceuticals, these copycat brands often bypass rigorous safety standards, making them a public health hazard. For eye care providers, this highlights the need for vigilant patient education regarding the dangers of purchasing unverified medical products online, especially as patients seek lower-cost alternatives to established brands.

Key Details

• The FDA specifically named South Moon, Rebright, and FivFivGo as the brands involved in this safety warning.
• The products are identified as 'copycat' eye drops, often designed to mimic the appearance or claims of reputable brands.
• The primary risk identified is potential bacterial contamination, which can cause sight-threatening infections.
• Consumers are urged to discard these products immediately if they have already purchased them.

Practice Implications

Optometrists and ophthalmologists should include specific questions about over-the-counter eye drop brands during patient intake, particularly for those presenting with signs of keratitis or conjunctivitis. Patients should be instructed to only purchase eye care products from reputable pharmacies and to avoid 'copycat' versions found on unregulated digital marketplaces.

Who's Affected

What's Next

The FDA is expected to continue its surveillance of online marketplaces to identify and remove other potentially harmful ophthalmic products. Clinicians should monitor the FDA’s MedWatch portal for updates on additional brands or specific adverse event reports related to these contaminated drops.